About almotriptan malate
Selective serotonin 5-HT1B/1D receptor agonist
Used for
- Acute treatment of migraine attacks, with or without aura.
Usual adult dose
12.5 mg once at migraine onset; if symptoms return, repeat after at least two hours. Maximum 25 mg in 24 hours.
Usual dose in children
For ages 12–17: 6.25 mg once; may repeat after at least two hours. Maximum 12.5 mg in 24 hours.
Common side effects
- Dizziness or drowsiness
- Nausea
- Tingling sensations
- Fatigue
Important warnings
- For migraine attacks only; not for prevention.
- Avoid with uncontrolled high blood pressure or significant heart or blood-vessel disease.
- Do not use with another triptan or ergot medicine within 24 hours.
- Seek urgent care for severe chest pain or signs of stroke.
Pregnancy
Human pregnancy data are limited; use requires weighing potential benefits and risks.
Breastfeeding
It is not known whether almotriptan enters human milk; discuss use with a healthcare professional.
Interactions
- Other triptans or ergot medicines increase serious blood-vessel effects.
- MAO inhibitors can raise almotriptan levels; avoid concurrent use and for two weeks afterward.
- SSRIs or SNRIs may increase the risk of serotonin syndrome.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.